Emmaus Life Sciences Reports 2022 Financial Results and Provides Business Update

TORRANCE, Calif., March 31, 2023 /PRNewswire/ — Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported its results of operation for the year ended December 31, 2022 and an update on recent…